CAR-T cells expressing IL-7 (for enhanced proliferation and survival) and CCL19 (for chemoattraction), called 7 × 19 CAR-T cells, enhanced anti-tumor activities and increased the infiltration of dendritic cells and T cells in the TME [149]. The gene discussed is IL7; the disease is neoplasm.